A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...

ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease LOS ANGELES, CA / ...

Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...

This RNA aptamer targets platelet adhesion in ischemic stroke, aiming to extend the treatment window beyond current time ...

Our End-of-Phase 2 meeting with FDA was productive and provided Lexicon with the insights needed to design a robust Phase 3 program, with the goal of making the first non-opioid DPNP medicine ...

Key market opportunities in the antibody optimization service industry include addressing rising chronic and complex diseases ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

A new study shows the intricacies of the cold virus and how it interacts with nasal airway cells, revealing why some people ...

Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...

Scientists at the University of Copenhagen discovered that smoking directly triggers the growth of visceral adipose tissue.

Agenus Inc. , a leader in immuno-oncology innovation, today announced the expansion of its global Medical Affairs infrastructure and early-access support capabilities in response to increasing ...